Previous close | 0.1030 |
Open | 0.0960 |
Bid | 0.0970 x N/A |
Ask | 0.1100 x N/A |
Day's range | 0.0960 - 0.0960 |
52-week range | 0.0950 - 0.9545 |
Volume | |
Avg. volume | 0 |
Market cap | 2.147M |
Beta (5Y monthly) | 3.35 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Blue Water (BWV) soars 62% after declaring its deal to purchase six FDA-approved products for $8.5 million. The agreement will help expand the company's portfolio into cardiology and pain management.
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...